Pediatrics
Commentary
Upper respiratory infections: Viral testing in primary care
Test results will help guide not only treatment decisions but also infection control measures.
News
FDA approves fixed dose combination topical treatment for acne
The new treatment combines three approved acne products for once-daily use.
News
Once-weekly topical therapy shows promise for moderate to severe acne
In vitro studies have found that components of S. lacustris, a freshwater sponge, have effects that include antimicrobial activity...
News
Metformin, weight management to stop type 2 diabetes in kids
“Weight stabilization and metformin therapy could be important interventions for diabetes prevention in children.”
Conference Coverage
New RSV vaccine will cut hospitalizations, study shows
With widespread use of the vaccine, annual hospitalizations resulting from infant RSV would fall by 51%, emergency department encounters would...
News
Patch testing finds higher prevalence of ACD among children with AD
AD and ACD both present with red, itchy, eczema-like patches and plaques and can be “really hard to differentiate.”
Commentary
Social media makes kids with type 1 diabetes feel less alone
I have had numerous patients – many of whom have struggled to accept their diagnosis – mention with joy and excitement that they were following an...
News
Preparing for the viral trifecta: RSV, influenza, and COVID-19
News
AHA updates CPR guidelines on cardiac arrest after poisoning
The update reflects treatment advances and new knowledge, including the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for...
News
European Commission grants approval of ritlecitinib for severe alopecia areata
In June of 2023, ritlecitinib was approved by the FDA for treatment of severe alopecia areata in people ages 12 and older in the United States.